At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ADIL Adial Pharmaceuticals
Not Yet Opened 05-02 16:00:00 EDT
1.79
+0.03
+1.70%
盘后1.83
+0.04+2.23%
19:58 EDT
High1.92
Low1.76
Vol245.30K
Open1.79
D1 Closing1.76
Amplitude8.90%
Mkt Cap7.26M
Tradable Cap7.05M
Total Shares4.05M
T/O449.76K
T/O Rate6.23%
Tradable Shares3.94M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Adial Pharmaceuticals Finalizes Separation Agreement with Dr. Johnson
BRIEF-Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting clinical Results Of AD04 As A Potential Treatment For Alcohol Use Disorder
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.